IL-1 receptor antagonist prevents apoptosis and caspase-3 activation after spinal cord injury

Journal of Neurotrauma

Volumn 18, Issue 9, 2001, Pages 947-956

  Nesic, Olivera ^a   Perez Polo, Regino ^a   Xu, Guo Ying ^b   McAdoo, David ^b   High, Karin Westlund ^b,c   Hulsebosch, Claire ^b,c  

^a Department of Human Biological Chemistry and Genetics ^*  (United States)

^b Marine Biomedical Institute   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

11 1 ; Apoptosis; Caspase 3; IL 1 receptor antagonist; Spinal cord injury

Indexed keywords

CASPASE 3; CYTOKINE; DNA FRAGMENT; INTERLEUKIN 1BETA; MESSENGER RNA; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; MALE; NERVOUS SYSTEM INJURY; NONHUMAN; OSMOTIC MINIPUMP; RAT; SPINAL CORD INJURY;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASES; ENZYME ACTIVATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIALOGLYCOPROTEINS; SPINAL CORD INJURIES;

EID: 0034856386     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/089771501750451857     Document Type: Article

References (65)

1. Interleukin-1 receptor antagonist: Role in biology
2. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: An in situ hybridization study
3. Graded histological and locomotor outcomes after spinal cord contusion using NYU weight drop device versus transection
4. Induction and regulation of interleukin-6 gene expression in rat astrocytes
5. Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination
6. Neutrophil accumulation after traumatic brain injury in rats: Comparison of weight drop and controlled cortical impact models
7. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys
8. Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme
9. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist
10. Interleukin-18
11. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord
12. Kainic acid induced expression of interleukin-1 receptor antagonist mRNA in the rat brain
13. Apoptosis after traumatic human spinal cord injury
14. Review: Transcriptional and posttranscriptional regulation of interleukin 1 gene expression
15. Expression of a dominant negative mutant of interleukin-1 converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischaemic brain injury
16. Functional role of interleukin-1 (IL-1) in IL-1 converting enzyme mediated apoptosis
17. The neurophatogenesis of HIV-1 infection
18. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease
19. Involvement of an intracellular adhesion molecule 1-dependent pathway in the pathogenesis of secondary changes after spinal cord injury in rats
20. Sequential mRNA expression for immediate early genes. Cytokines and neurotrophines in spinal cord injury
21. Brain macrophages synthesize interleukin-1 and interleukin-1 mRNAs in vitro
22. beta and induction of inflammation, apoptosis, and vasogenic edema
23. Cytokines and the nervous system I. Expression and recognition
24. Rodent model of chronic central pain after spinal cord injury
25. Granzyme A is an interleukin 1 beta-converting enzyme
26. Induction and its spread of apoptosis in rat spinal cord after mechanical trauma
27. Effects of pro-inflammatory cytokines in experimental spinal cord injury
28. Experimental axonal injury triggers interleukin-6 mRNA, protein synthesis and release into cerebrospinal fluid
29. Interleukin-1 and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat
30. beta promoter is regulated by a transcriptional repressor
31. Deciphering the pathways of life and death
32. Neuronal and glial apoptosis after traumatic spinal cord injury
33. Neurotoxicity of glutamate at the concentration released upon spinal cord injury
34. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat
35. In vivo Bcl-2 oncogene neuronal expression in the rat spinal cord
36. Acute-phase responses in transgenic mice with CNS overexpression of IL-1 receptor antagonist
37. The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in rat model of hypoxia-ischemia
38. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis
39. Induction of apoptosis signal regulating kinase 1 (ASK1) after spinal cord injury in rats: Possible involvement of ASK1-JNK and -p38 pathways in neuronal apoptosis
40. Transient global forebrain ischemia induces a prolonged expression of the caspase-3 mRNA in rat hippocampal CA1 pyramidal neurons
41. The neuroprotective effects of the recombinant interleukin-1 receptor antagonist rhIL-1ra after excitotoxic stimulation with kainic acid and its relationship to the amyloid precursor protein gene
42. beta enhances spinal cord blood flow after intrathecal administration in the normal rat
43. Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp-chloromethyl ketone induces long-lasting neuro-protection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokines
44. Neurological activation repertoire in the injured brain: Graded response, molecular mechanisms and cues to physiological function
45. Peripheral administration of interleukin-1 receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat
46. Interleukins and cerebral ischaemia
47. Cytokines - Killers in the brain?
48. Implications of p53 protein expression in experimental spinal cord injury
49. Interleukin-1 receptor antagonist attenuates regional neuronal cell death and cognitive dysfunction after experimental brain injury
50. Rapid detection of octamer binding proteins with "mini-extracts" prepared from a small number of cells
51. beta+ astrocytes with neurofibrillary tangle stages
52. High dose methylprednisolone in the management of acute spinal cord injury - A systematic review from a clinical perspective
53. Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats
54. Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury
55. Cytokine mRNA profiles in contused spinal cord and axotomized facila nucleus suggests a beneficial role for inflammation and glisosis
56. Possible involvement of interleukin-1 cyclooxygenase-2 induction after spinal cord injury in rats
57. Deafferentation and central pain
58. Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat
59. New assessment techniques for evaluation of post-traumatic spinal cord function in the rat
60. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: Functional evidence for enhancement of electrographic seizures
61. Apoptosis followed spinal cord injury in rats and preventive effect of N-methyl-D-aspartated receptor antagonist
62. Increase of interleukin-1beta mRNA and protein in the spinal cord following experimental traumatic injury in the rat
63. Sequential expression of c-fos protooncogene, TNF-alpha and dynorphin genes in spinal cord following experimental traumatic injury
64. Apoptosis in cellular compartments of rat spinal cord after severe contusion injury
65. Cerebral vessels express interleukin 1-beta after focal cerebral ischemia